Conformation depends on 4D-QSAR analysis using EC-GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors.

about

4D-QSAR investigation and pharmacophore identification of pyrrolo[2,1-c][1,4]benzodiazepines using electron conformational-genetic algorithm method.

P2860

Q39816650-5A6C1604-261B-4F75-956B-2740E440EE5A

P2860

Conformation depends on 4D-QSAR analysis using EC-GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors.

Item

http://www.wikidata.org/entity/Q51367473

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Conformation depends on 4D-QSA ...... erse transcriptase inhibitors.

@en

Conformation depends on 4D-QSA ...... erse transcriptase inhibitors.

@nl

type

Item

label

Conformation depends on 4D-QSA ...... erse transcriptase inhibitors.

@en

Conformation depends on 4D-QSA ...... erse transcriptase inhibitors.

@nl

prefLabel

Conformation depends on 4D-QSA ...... erse transcriptase inhibitors.

@en

Conformation depends on 4D-QSA ...... erse transcriptase inhibitors.

@nl

P1476

Conformation depends on 4D-QSA ...... verse transcriptase inhibitors

@en

P2093

Emin Sarıpınar

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TIBO) derivatives

New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs

Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs)

The HIV-1 reverse transcription (RT) process as target for RT inhibitors

Best Practices for QSAR Model Development, Validation, and Exploitation

P304

776-791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14756366.2012.684051

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Akyüz

P577

2012-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22591319

http://www.w3.org/2001/XMLSchema#string

Conformation depends on 4D-QSAR analysis using EC-GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors.

about

P2860

P2860

Conformation depends on 4D-QSAR analysis using EC-GA method: pharmacophore identification and bioactivity prediction of TIBOs as non-nucleoside reverse transcriptase inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698